Skip to content

CalAmp CAMP Book value per share

Book value per share at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.98-0.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$9.98+23.2%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$0.72-271%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$0.58+183%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$1.80+528%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

Based on the most recent quarter.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's book value per share?
CalAmp (CAMP) reported book value per share of $0.53 in Q1 2026.
How has CalAmp's book value per share changed year-over-year?
CalAmp's book value per share decreased by 79.2% year-over-year, from $2.56 to $0.53.
What is the long-term trend for CalAmp's book value per share?
Over 2 years (2023 to 2025), CalAmp's book value per share has grown at a -92.9% compound annual growth rate (CAGR), from -$313.26 to $1.57.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.